Methyl 2-Oxoindoline-6-Carboxylate CAS 14192-26-8 Purity > 99.0% (HPLC) Nintedanib Esylate Intermediate Hoobkas Featured duab

Methyl 2-Oxoindoline-6-Carboxylate CAS 14192-26-8 Purity > 99.0% (HPLC) Nintedanib Esylate Intermediate Factory

Lus piav qhia luv luv:

Lub npe tshuaj: Methyl 2-Oxoindoline-6-Carboxylate

CAS: 14192-26-8 Nr

Purity:> 99.0% (HPLC)

Cov tsos mob: Lub teeb daj rau xim av hmoov

Intermediate ntawm Nintedanib Esylate (CAS: 656247-18-6) hauv kev kho mob ntawm cov qog nqaij hlav tsis me me & idiopathic pulmonary fibrosis (IPF)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Xa email rau peb

Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Shanghai Ruifu Chemical Co., Ltd. yog cov chaw tsim khoom thiab cov chaw muag khoom ntawm Methyl 2-Oxoindoline-6-Carboxylate (CAS: 14192-26-8) nrog cov khoom zoo, kev lag luam ntau lawm.

Chemical Properties:

Tshuaj npe	Methyl 2-Oxoindoline-6-Carboxylate
Synonyms	2-Oxoindoline-6-Carboxylic Acid Methyl Ester;Methyl Oxindole-6-Carboxylate
CAS Nr	14192-26-8 ib
CAT Number	Qauv TSIS MUAJ: RF-PI1524
Tshuag xwm txheej	Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula	C10H9NO3
Molecular Luj	191.19 Nws
Melting Point	184.0 ~ 190.0 ℃
Hom	Ruifu Tshuaj

Specifications:

Yam khoom	Specifications
Qhov tshwm sim	Lub teeb daj rau xim av hmoov
1 H NMR Spectrum	Raws li tus qauv
Purity / Analysis Method	> 99.0% (HPLC)
Poob rau ziab	<1.00%
Tag nrho cov impurities	<1.00%
Test Standard	Enterprise Standard
Kev siv	Nintedanib Esylate (CAS: 656247-18-6)

Methyl 2-Oxoindoline-6-Carboxylate (CAS: 14192-26-8) Synthetic Route

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.

Qhov zoo:

FAQ:

Daim ntawv thov:

Methyl 2-Oxoindoline-6-Carboxylate (CAS: 14192-26-8) yog ib qho nruab nrab siv los npaj Nintedanib Esylate (CAS: 656247-18-6).Nintedanib Esylate yog ib qho muaj zog, qhov ncauj triple angiokinase inhibitor tsim los ntawm Boehringer Ingelheim uas lub hom phiaj proangiogenic thiab pro-fibrotic txoj kev kho los ntawm vascular endothelial kev loj hlob receptor, fibroblast kev loj hlob receptor thiab plateletderived kev loj hlob receptor tsev neeg, nrog rau Src thiab Flt-3. kinases.Nintedanib Esylate tau txais kev pom zoo rau kev kho mob ntawm idiopathic pulmonary fibrosis (IPF), ib qho mob uas lub ntsws ua kom muaj caws pliav nyob rau lub sijhawm, los ntawm US FDA thaum Lub Kaum Hli 2014 thiab los ntawm EMA thaum Lub Ib Hlis 2015. FDA tau tso cai nintedanib esylate nrawm nrawm. , kev tshuaj xyuas qhov tseem ceeb, cov khoom lag luam me nyuam ntsuag, thiab kev ua tiav cov npe.Nws kuj tau txais kev pom zoo los ntawm EMA thaum lub Kaum Ib Hlis 2014 rau kev kho mob ntawm cov qog nqaij hlav tsis me me hauv lub ntsws ua ke nrog docetaxel tom qab thawj kab tshuaj kho mob.